We examine AXA candidates to understand their impact on human biology via human Non-IND clinical studies. We use that information to inform an application decision for either a consumer or drug product.
Below are potential consumer health† or disease target areas that could apply to each of our AXA candidates.
*Axcella conducts Non-IND, IRB-approved food studies to evaluate the safety and tolerability of its AXA candidates in human subjects, or effects on the normal structure or function of the body. Studies intended to directly support drug development will be conducted under an IND.